This is the case in a variety of tested permutations (RI, F2, and AIL populations) at tested markers.
All other tested markers were negative (HSP72) or showed a normal staining pattern (MAP2; Fig. 3).
Except for CD207 and CD11R3, this sub population does not express other tested markers.
We tested markers from the 23 European GWS loci from our previous scans and a meta-analysis [9], [10], [12].
At least three tested markers have the same flanking regions as do markers near the X centromere region.
We tested markers from all 23 European GWS loci that we identified in our previous scans and a meta-analysis [9], [10], [12].
Four days after treatment, although Otx2 protein was strongly reduced, we observed no change in expression of most tested markers including rhodopsin (Fig 3B), with one exception, IRBP whose staining appeared decreased.
The results for the markers associating with spine and hip BMD in East-Asians are shown in Table 2 and Table 3, respectively, and the results for all the tested markers are shown in Table S2 and Table S3.
No divergence from Hardy-Weinberg equilibrium observed for any of the tested markers.
The blast analysis indicated that of the 453 tested markers, 389 had hits in foxtail genomes.
Of the 2,138 EST-SSR primer pairs tested, markers derived from 598 could be mapped.
